- Home
- CIEN vs SNN Comparison
CIEN vs SNN Comparison
Compare CIEN & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIEN | SNN |
|---|---|---|
| Founded | 1992 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Industrial Specialties |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.3B | 14.0B |
| IPO Year | 1997 | 1999 |
Fundamental Metrics
Financial Performance| Metric | CIEN | SNN |
|---|---|---|
| Price | $200.42 | $33.44 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 4 |
| Target Price | ★ $152.36 | $32.83 |
| AVG Volume (30 Days) | ★ 3.5M | 476.9K |
| Earning Date | 12-11-2025 | 03-02-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | 3.32 | ★ 59.91 |
| EPS | ★ 0.98 | 0.56 |
| Revenue | $4,541,635,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $19.58 | $7.78 |
| Revenue Next Year | $16.89 | $5.13 |
| P/E Ratio | $205.91 | ★ $29.10 |
| Revenue Growth | ★ 12.97 | 5.35 |
| 52 Week Low | $49.21 | $23.69 |
| 52 Week High | $214.17 | $38.79 |
Technical Indicators
Market Signals| Indicator | CIEN | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 58.28 | 48.01 |
| Support Level | $186.39 | $32.68 |
| Resistance Level | $209.19 | $33.56 |
| Average True Range (ATR) | 10.53 | 0.41 |
| MACD | -0.80 | 0.14 |
| Stochastic Oscillator | 79.72 | 78.51 |
Price Performance
Historical ComparisonAbout CIEN Ciena Corporation
Ciena is a telecommunications equipment provider focused on optical transport technologies, with clients in a number of industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises worldwide. The company provides equipment, software, and services that support transport, switching, aggregation, service delivery, and data traffic management.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.